We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+7.34%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$14.8B
AUM Growth
+$2.13B
(+17%)
Cap. Flow
+$1.52B
Cap. Flow
% of AUM
10.28%
Top 10 Holdings %
Top 10 Hldgs %
17.14%
Holding
1,089
New
119
Increased
321
Reduced
473
Closed
155
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$132M |
| 2 |
Apple
AAPL
|
+$117M |
| 3 |
Microsoft
MSFT
|
+$100M |
| 4 |
Fidelity National Information Services
FIS
|
+$94.3M |
| 5 |
FedEx
FDX
|
+$91.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$97.2M |
| 2 |
Booking.com
BKNG
|
+$94.2M |
| 3 |
Phillips 66
PSX
|
+$82.9M |
| 4 |
Gilead Sciences
GILD
|
+$73.9M |
| 5 |
Snowflake
SNOW
|
+$51.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.09% |
| 2 | Financials | 15.5% |
| 3 | Healthcare | 14.12% |
| 4 | Consumer Discretionary | 11.36% |
| 5 | Industrials | 9.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Emergent Biosolutions
EBS
$377M
| $14.8M | 0.1% |
1,253,042
+284,536
| +29% | +$4.4M |
|
227
Telephone and Data Systems
TDS
$3.87B
| $14.8M | 0.1% |
1,408,677
+1,028,121
| +270% | +$12.7M |
|
228
Otis Worldwide
OTIS
$28B
| $14.6M | 0.1% |
186,181
+34,649
| +23% | +$2.56M |
|
229
Adobe
ADBE
$99B
| $14.6M | 0.1% |
43,286
+4,381
| +11% | +$1.4M |
|
230
Viavi Solutions
VIAV
$8.66B
| $14.4M | 0.1% |
+1,370,622
| New | +$16.5M |
|
|
PRMW
231
DELISTED
Primo Water Corporation
PRMW
| $14.2M | 0.1% |
912,867
-95,876
| -10% | -$1.39M |
|
232
Andersons Inc
ANDE
$2.49B
| $14.2M | 0.1% |
404,867
-10,749
| -3% | -$382K |
|
|
CSGS
233
DELISTED
CSG Systems International
CSGS
| $14.1M | 0.1% |
246,934
-62,617
| -20% | -$3.68M |
|
|
BAND
234
Bandwidth Inc
BAND
$1.67B
| $14M | 0.09% |
610,183
-48,889
| -7% | -$889K |
|
235
Highwoods Properties
HIW
$3.71B
| $14M | 0.09% |
500,012
-103,363
| -17% | -$2.87M |
|
236
AdvanSix
ASIX
$551M
| $13.9M | 0.09% |
364,337
-4,372
| -1% | -$164K |
|
|
AVTA
237
DELISTED
Avantax, Inc. Common Stock
AVTA
| $13.7M | 0.09% |
538,000
-10,779
| -2% | -$247K |
|
238
Patterson-UTI
PTEN
$3.48B
| $13.7M | 0.09% |
+810,667
| New | +$13.4M |
|
239
GoPro
GPRO
$125M
| $13.5M | 0.09% |
2,720,825
+386,787
| +17% | +$2.03M |
|
240
Cerence
CRNC
$368M
| $13.5M | 0.09% |
726,636
+233,323
| +47% | +$4M |
|
241
Plains GP Holdings
PAGP
$5.2B
| $13.4M | 0.09% |
1,074,443
-417,878
| -28% | -$5.21M |
|
|
AVID
242
DELISTED
Avid Technology Inc
AVID
| $13.3M | 0.09% |
502,036
-12,051
| -2% | -$317K |
|
243
CoreCivic
CXW
$3.03B
| $13.3M | 0.09% |
1,152,141
-416,796
| -27% | -$4.63M |
|
244
OFG Bancorp
OFG
$2.24B
| $13.2M | 0.09% |
479,328
-2,666
| -0.6% | -$73.2K |
|
245
Agios Pharmaceuticals
AGIO
$2.14B
| $13.2M | 0.09% |
468,746
-17,980
| -4% | -$507K |
|
246
Health Catalyst
HCAT
$158M
| $13.1M | 0.09% |
1,228,489
+690,711
| +128% | +$6.67M |
|
|
ARCH
247
DELISTED
Arch Resources, Inc.
ARCH
| $13M | 0.09% |
91,210
+15,966
| +21% | +$2.34M |
|
248
Alignment Healthcare
ALHC
$3.81B
| $12.9M | 0.09% |
1,098,488
+472,507
| +75% | +$5.75M |
|
249
Ashland
ASH
$3.11B
| $12.8M | 0.09% |
119,391
-416
| -0.3% | -$43.8K |
|
250
Park Hotels & Resorts
PK
$3.06B
| $12.8M | 0.09% |
1,084,994
-40,282
| -4% | -$491K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2022 Portfolio in Review
As of Q4 2022, Jacobs Levy Equity Management held 1,089 positions worth $14.8B, up 17% from $12.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Jacobs Levy Equity Management deployed $1.52B of net new capital in Q4 2022, opening 119 new positions and adding to 321 existing holdings. Its largest new stake was Fidelity National Information Services: 1,326,663 shares worth $90M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Booking.com, an estimated $94.2M trimmed.
- Jacobs Levy Equity Management's largest Q4 2022 buy was Fidelity National Information Services: 1,326,663 shares worth $90M.
- Jacobs Levy Equity Management added most to Vertex Pharmaceuticals in Q4 2022, an estimated $132M increase.
- Jacobs Levy Equity Management's biggest Q4 2022 reduction was Booking.com, cutting an estimated $94.2M.
- Jacobs Levy Equity Management fully exited Cigna in Q4 2022, selling an estimated $97.2M.
- Jacobs Levy Equity Management's ten largest holdings make up 17% of its $14.8B portfolio in Q4 2022.
- Jacobs Levy Equity Management opened 119 new positions and closed 155 in Q4 2022.
- Jacobs Levy Equity Management's portfolio value rose 17% quarter-over-quarter to $14.8B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2022, filed 14 Feb 2023.